{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:18:40Z","timestamp":1790774320630,"version":"4.1.0"},"reference-count":19,"publisher":"American Diabetes Association","issue":"1","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,1,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To describe the beneficial long-term effects of an average of 6.5 years of intensive diabetes therapy (INT) in type 1 diabetes on measures of atherosclerosis, cardiac structure and function, and clinical cardiovascular events observed in the Diabetes Control and Complications Trial (DCCT) and the Epidemiology of Diabetes Interventions and Complications (EDIC) study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>The DCCT was a randomized clinical trial of 1,441 participants assigned to receive INT or conventional therapy (CON). It was conducted between 1983\u20131993 with an average follow-up of 6.5 years. EDIC (1994\u2013present) is an observational follow-up of the DCCT cohort. Cardiovascular events have been recorded throughout. During EDIC common carotid intima-media thickness (IMT) was measured with ultrasound, coronary artery calcification with computed tomography, and cardiac structure and function with cardiac magnetic resonance imaging.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>DCCT INT and lower levels of HbA1c during DCCT\/EDIC were associated with thinner carotid IMT, less coronary calcification, and a lower incidence of clinical cardiovascular events including myocardial infarction, stroke, and cardiac death. While there were no significant differences in cardiac structure and function between the former INT and CON groups, they were significantly associated with higher HbA1c during DCCT\/EDIC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>DCCT INT and the attendant 6.5 years of lower HbA1c had long-term salutary effects on the development and progression of atherosclerosis and cardiovascular disease during the subsequent follow-up during EDIC.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc13-2116","type":"journal-article","created":{"date-parts":[[2013,12,27]],"date-time":"2013-12-27T23:14:52Z","timestamp":1388186092000},"page":"39-43","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":179,"title":["Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study"],"prefix":"10.2337","volume":"37","author":[{"given":"John M.","family":"Lachin","sequence":"first","affiliation":[{"name":"Biostatistics Center, The George Washington University, Rockville, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor J.","family":"Orchard","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Nathan","sequence":"additional","affiliation":[{"name":"Diabetes Center and Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the DCCT\/EDIC Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2013,12,11]]},"reference":[{"key":"2022031222142832300_B1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"2022031222142832300_B2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM200002103420603","article-title":"Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy","volume":"342","author":"Lachin","year":"2000","journal-title":"N Engl J Med"},{"key":"2022031222142832300_B3","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/db07-1618","article-title":"Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial\u2014revisited","volume":"57","author":"Lachin","year":"2008","journal-title":"Diabetes"},{"key":"2022031222142832300_B4","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1001\/jama.290.16.2159","article-title":"Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study","volume":"290","author":"Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2003","journal-title":"JAMA"},{"key":"2022031222142832300_B5","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.2337\/dc06-1161","article-title":"Type 1 diabetes and coronary artery disease","volume":"29","author":"Orchard","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031222142832300_B6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11892-009-0089-3","article-title":"When are type 1 diabetic patients at risk for cardiovascular disease?","volume":"10","author":"Orchard","year":"2010","journal-title":"Curr Diab Rep"},{"key":"2022031222142832300_B7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s12265-012-9363-x","article-title":"Cardiovascular disease risk in young people with type 1 diabetes","volume":"5","author":"Snell-Bergeon","year":"2012","journal-title":"J Cardiovasc Transl Res"},{"key":"2022031222142832300_B8","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0002-9149(99)80683-3","article-title":"Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial","volume":"75","author":"The Diabetes Control and Complications Trial Research Group","year":"1995","journal-title":"Am J Cardiol"},{"key":"2022031222142832300_B9","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"2022031222142832300_B10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2337\/diabetes.48.2.383","article-title":"Effect of intensive diabetes treatment on carotid artery wall thickness in the Epidemiology of Diabetes Interventions and Complications","volume":"48","author":"Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group","year":"1999","journal-title":"Diabetes"},{"key":"2022031222142832300_B11","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMoa022314","article-title":"Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus","volume":"348","author":"Nathan","year":"2003","journal-title":"N Engl J Med"},{"key":"2022031222142832300_B12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2337\/db10-0296","article-title":"DCCT\/EDIC Research Group. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) study","volume":"60","author":"Polak","year":"2011","journal-title":"Diabetes"},{"key":"2022031222142832300_B13","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.2337\/db06-0653","article-title":"The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study","volume":"55","author":"Cleary","year":"2006","journal-title":"Diabetes"},{"key":"2022031222142832300_B14","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1161\/CIRCULATIONAHA.111.022327","article-title":"Myocardial structure, function, and scar in patients with type 1 diabetes mellitus","volume":"124","author":"Turkbey","year":"2011","journal-title":"Circulation"},{"key":"2022031222142832300_B15"},{"key":"2022031222142832300_B16"},{"key":"2022031222142832300_B17","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031222142832300_B18","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031222142832300_B19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/37\/1\/39\/617413\/39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/37\/1\/39\/617413\/39.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T00:28:58Z","timestamp":1647131338000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/37\/1\/39\/32077\/Update-on-Cardiovascular-Outcomes-at-30-Years-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,11]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,11]]},"published-print":{"date-parts":[[2014,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc13-2116","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,11]]}}}